Tandem Diabetes Care Inc. (TNDM)

64.93
1.10 1.60
NASDAQ : Health Technology
Prev Close 63.88
Open 63.78
Day Low/High 63.72 / 65.97
52 Wk Low/High 26.40 / 74.81
Volume 1.03M
Avg Volume 1.26M
Exchange NASDAQ
Shares Outstanding 58.65M
Market Cap 3.61B
EPS -2.50
P/E Ratio N/A
Div & Yield N.A. (N.A)
Tandem Diabetes Care Approved As Insulin Pump Vendor For ADP In Ontario, Canada

Tandem Diabetes Care Approved As Insulin Pump Vendor For ADP In Ontario, Canada

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that it is now registered as an approved vendor of insulin pumps and supplies under the Assistive Devices Program (ADP) in Ontario,...

Tandem Diabetes Care Announces Upcoming Conference Presentations

Tandem Diabetes Care Announces Upcoming Conference Presentations

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that John Sheridan, president and chief executive officer, will present at the following upcoming investor conferences: Cowen 39 th...

Tandem Diabetes Care Announces Plan To Use Remote Software Update Tool In Ongoing Clinical Trial

Tandem Diabetes Care Announces Plan To Use Remote Software Update Tool In Ongoing Clinical Trial

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that it intends to use its remote software update tool, the Tandem Device Updater, to resolve a Control-IQ technology software anomaly...

A Technical Strategy for Tandem Diabetes Care

A Technical Strategy for Tandem Diabetes Care

Are we late to the game with the stock up so much?

Your Game Plan: Cramer's 'Mad Money' Recap (Friday 3/1/19)

Your Game Plan: Cramer's 'Mad Money' Recap (Friday 3/1/19)

Jim Cramer has your game plan for next week: Keep a sharp eye out for the Fed and the employment data.

Tandem Diabetes Care Announces Succession Plan For Chief Executive Officer And Board Of Directors

Tandem Diabetes Care Announces Succession Plan For Chief Executive Officer And Board Of Directors

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced a succession plan for its chief executive officer (CEO) and select members of its board of directors.

Tandem Diabetes Care Reports 2018 Financial Results And 2019 Financial Guidance

Tandem Diabetes Care Reports 2018 Financial Results And 2019 Financial Guidance

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today reported its financial results for the quarter and year ended December 31, 2018 and financial guidance for the year ending December 31, 2019.

Tandem Diabetes Care Appoints New Senior Vice President To Drive Expansion Of Digital Health And Information Technology Initiatives

Tandem Diabetes Care Appoints New Senior Vice President To Drive Expansion Of Digital Health And Information Technology Initiatives

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced the appointment of Manuel Jaime as its new Senior Vice President, Technology and Digital Health.

T:slim X2 Insulin Pump First To Receive New ACE Pump Classification By FDA

T:slim X2 Insulin Pump First To Receive New ACE Pump Classification By FDA

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that the U.

Tandem Diabetes Care To Announce Fourth Quarter And Full Year 2018 Financial Results On February 26, 2019

Tandem Diabetes Care To Announce Fourth Quarter And Full Year 2018 Financial Results On February 26, 2019

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its fourth quarter and full year 2018 results after the financial markets close on Tuesday, February 26, 2019.

Take-Two Interactive, Cliffs Natural Resources: 'Mad Money' Lightning Round

Take-Two Interactive, Cliffs Natural Resources: 'Mad Money' Lightning Round

Jim Cramer takes a look at Take-Two Interactive, Sina, Cliffs Natural Resources, Public Service Enterprise, Annaly Capital, Neutral Tandem and more.

From Bear Back to Bull: Cramer's 'Mad Money' Recap (Thursday 1/10/19)

From Bear Back to Bull: Cramer's 'Mad Money' Recap (Thursday 1/10/19)

Jim Cramer says it looks like the bulls are no longer fighting the Fed or the tape.

Tandem Diabetes Care Announces Appointment Of Rebecca Robertson As Board Member

Tandem Diabetes Care Announces Appointment Of Rebecca Robertson As Board Member

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that Rebecca (Beckie) Robertson was appointed as an independent member of its board of directors.

February 22nd Options Now Available For Tandem Diabetes Care (TNDM)

February 22nd Options Now Available For Tandem Diabetes Care (TNDM)

Investors in Tandem Diabetes Care Inc saw new options begin trading today, for the February 22nd expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the TNDM options chain for the new February 22nd contracts and identified one put and one call contract of particular interest.

Keeping An Eye on Tandem Diabetes Care

Keeping An Eye on Tandem Diabetes Care

It's not a good idea to try to chase the last two days' moves going into an end-of-year holiday weekend.

Tandem Diabetes Care To Present At The Credit Suisse Healthcare Conference

Tandem Diabetes Care To Present At The Credit Suisse Healthcare Conference

Tandem Diabetes Care ®, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that Kim Blickenstaff, President and Chief Executive Officer and Leigh Vosseller, EVP and Chief Financial Officer, will present at the...

Tandem Diabetes Care Honored In San Diego 2018 Top Workplaces Awards From San Diego Union-Tribune

Tandem Diabetes Care Honored In San Diego 2018 Top Workplaces Awards From San Diego Union-Tribune

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced it has been named a top workplace in San Diego by The San Diego Union-Tribune and awarded a "Future Forward" 2018 Top Workplaces honor.

Tandem Diabetes Care Announces Upcoming Conference Presentations

Tandem Diabetes Care Announces Upcoming Conference Presentations

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present at the following upcoming investor conferences: Stifel 2018 Healthcare Conference on Tuesday, November 13,...

Tandem Diabetes Care Reports Third Quarter 2018 Financial Results

Tandem Diabetes Care Reports Third Quarter 2018 Financial Results

Tandem Diabetes Care ®, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today reported its financial results for the quarter ended September 30, 2018.

Tandem Diabetes Care To Announce Third Quarter 2018 Financial Results On November 1, 2018

Tandem Diabetes Care To Announce Third Quarter 2018 Financial Results On November 1, 2018

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps with continuous glucose monitoring integration, plans to release its third quarter 2018 results after the financial markets close...

Tandem Diabetes Care Receives Health Canada Approval To Market T:slim X2 Insulin Pump

Tandem Diabetes Care Receives Health Canada Approval To Market T:slim X2 Insulin Pump

Tandem Diabetes Care ®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps with continuous glucose monitoring (CGM) integration, today announced that it has received a Heath Canada Medical Device License...

First Week Of May 2019 Options Trading For Tandem Diabetes Care (TNDM)

First Week Of May 2019 Options Trading For Tandem Diabetes Care (TNDM)

Investors in Tandem Diabetes Care Inc saw new options begin trading this week, for the May 2019 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 217 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

GE and AMD Are Among 10 Big-Name Stocks Ready to Reverse Direction

GE and AMD Are Among 10 Big-Name Stocks Ready to Reverse Direction

These names are showing technical characteristics of either bullish or bearish reversal patterns over the past week.

Tandem Diabetes Care Increases 2018 Sales Guidance And Provides Estimated Third Quarter Sales Results

Tandem Diabetes Care Increases 2018 Sales Guidance And Provides Estimated Third Quarter Sales Results

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps with continuous glucose monitoring integration, today announced that it has increased its 2018 sales guidance to $150 million to...

TNDM Crosses Above Average Analyst Target

TNDM Crosses Above Average Analyst Target

In recent trading, shares of have crossed above the average analyst 12-month target price of $43.00, changing hands for $43.18/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Tandem Diabetes Care To Webcast Investor & Analyst Day On September 25, 2018

Tandem Diabetes Care To Webcast Investor & Analyst Day On September 25, 2018

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps with continuous glucose monitoring integration, today announced it will host an Institutional Investor and Analyst Day from 8:30am...

Tandem Diabetes Care To Present At The Baird Global Healthcare Conference

Tandem Diabetes Care To Present At The Baird Global Healthcare Conference

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps with continuous glucose monitoring integration, today announced that Kim Blickenstaff, president and CEO, will present a company...

Tandem Diabetes Care Announces Commercial Launch Of T:slim X2 Insulin Pump With Basal-IQ Technology In The United States

Tandem Diabetes Care Announces Commercial Launch Of T:slim X2 Insulin Pump With Basal-IQ Technology In The United States

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps with continuous glucose monitoring (CGM) integration, today announced its launch of the t:slim X2™ Insulin Pump with Basal-IQ™...

Tandem Diabetes Care Announces Full Repayment Of Outstanding CRG Debt

Tandem Diabetes Care Announces Full Repayment Of Outstanding CRG Debt

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps with continuous glucose monitoring (CGM) integration, today announced that it has fully repaid its term loan made by Capital...

Tandem Diabetes Care Announces Publication Of PROLOG Study Results In Diabetes Care Journal

Tandem Diabetes Care Announces Publication Of PROLOG Study Results In Diabetes Care Journal

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps with continuous glucose monitoring (CGM) integration, today announced the online publication of results from the PROLOG (PLGS for...

TheStreet Quant Rating: D- (Sell)